Janumet



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 42.0%
Diabetes Mellitus 27.6%
Hypertension 13.9%
Product Used For Unknown Indication 2.2%
Dyslipidaemia 2.1%
Hypercholesterolaemia 1.5%
Blood Glucose 1.1%
Insulin-requiring Type 2 Diabetes Mellitus 1.1%
Coronary Artery Disease 1.0%
Hyperlipidaemia 0.9%
Hypothyroidism 0.9%
Atrial Fibrillation 0.9%
Gastrooesophageal Reflux Disease 0.9%
Depression 0.7%
Pain 0.6%
Type 1 Diabetes Mellitus 0.6%
Cardiac Failure 0.5%
Benign Prostatic Hyperplasia 0.5%
Blood Cholesterol Increased 0.5%
Blood Glucose Increased 0.5%
Pancreatitis 25.9%
Pancreatic Carcinoma 6.8%
Vomiting 6.1%
Weight Decreased 6.0%
Pancreatitis Acute 5.4%
Diarrhoea 5.2%
Renal Failure 5.2%
Renal Failure Acute 4.7%
Drug Ineffective 3.7%
Hypoglycaemia 3.7%
Lipase Increased 3.4%
Nausea 3.0%
Wrong Technique In Drug Usage Process 3.0%
Death 2.8%
Myocardial Infarction 2.8%
Inappropriate Schedule Of Drug Administration 2.6%
Lactic Acidosis 2.6%
Rash 2.6%
Oedema Peripheral 2.3%
Pruritus 2.3%
Secondary
Type 2 Diabetes Mellitus 33.5%
Diabetes Mellitus 16.5%
Hypertension 16.0%
Product Used For Unknown Indication 9.0%
Hyperlipidaemia 2.8%
Hypersensitivity 2.6%
Gastrooesophageal Reflux Disease 2.6%
Asthma 1.8%
Blood Glucose 1.8%
Drug Use For Unknown Indication 1.6%
Depression 1.5%
Hypertriglyceridaemia 1.5%
Hyperuricaemia 1.4%
Hypercholesterolaemia 1.3%
Migraine 1.1%
Pain 1.1%
Chest Pain 1.0%
Dyslipidaemia 1.0%
Anxiety 0.9%
Diabetic Neuropathy 0.9%
Pancreatitis 17.1%
Pancreatic Carcinoma 9.7%
Liver Injury 8.3%
Renal Failure Acute 7.4%
Wrong Technique In Drug Usage Process 6.5%
Weight Decreased 5.1%
Vomiting 4.6%
Overdose 4.2%
Blood Glucose Increased 3.7%
Memory Impairment 3.7%
Nausea 3.7%
Hypoglycaemia 3.2%
Inappropriate Schedule Of Drug Administration 3.2%
Pancreatitis Acute 3.2%
Diarrhoea 2.8%
Drug Hypersensitivity 2.8%
Incorrect Dose Administered 2.8%
Lipase Increased 2.8%
Urinary Tract Infection 2.8%
Headache 2.3%
Concomitant
Product Used For Unknown Indication 38.1%
Diabetes Mellitus 12.5%
Drug Use For Unknown Indication 11.1%
Hypertension 9.2%
Type 2 Diabetes Mellitus 7.8%
Blood Cholesterol Increased 3.7%
Rheumatoid Arthritis 1.9%
Atrial Fibrillation 1.8%
Depression 1.7%
Blood Triglycerides Increased 1.5%
Asthma 1.4%
Pain 1.3%
Prophylaxis 1.2%
Blood Pressure 1.1%
Gastrooesophageal Reflux Disease 1.0%
High Density Lipoprotein Decreased 1.0%
Cardiac Disorder 0.9%
Hepatitis C 0.9%
Hypothyroidism 0.9%
Psoriasis 0.9%
Flushing 10.6%
Blood Glucose Increased 9.4%
Pruritus 8.4%
Vomiting 8.1%
Weight Decreased 5.8%
Drug Ineffective 5.6%
Nausea 5.6%
Weight Increased 5.4%
Diarrhoea 4.6%
Paraesthesia 4.0%
Myocardial Infarction 3.8%
Pain 3.6%
Dyspnoea 3.5%
Pain In Extremity 3.5%
Urticaria 3.5%
Urinary Tract Infection 3.3%
Injection Site Pain 3.1%
Skin Burning Sensation 3.1%
Pancreatitis 2.7%
Rash 2.7%
Interacting
Product Used For Unknown Indication 20.0%
Diabetes Mellitus 12.0%
Essential Hypertension 12.0%
Hyperlipidaemia 8.0%
Type 2 Diabetes Mellitus 8.0%
Abdominal Discomfort 4.0%
Asthenia 4.0%
Blood Cholesterol Increased 4.0%
Depression 4.0%
Diarrhoea 4.0%
Fluid Retention 4.0%
Gastrooesophageal Reflux Disease 4.0%
Hypertension 4.0%
Myocardial Ischaemia 4.0%
Nephrolithiasis 4.0%
Drug Interaction 22.2%
Renal Disorder 22.2%
Trabeculectomy 22.2%
Hyperhidrosis 11.1%
Personality Change 11.1%
Speech Disorder 11.1%